The promoters of OneSource Specialty Pharma Limited, a TPG Growth-backed specialty pharma contract development and manufacturing organisation (CDMO), are in discussions with a clutch of investors including White Oak Capital Management Consultants LLP, Swiss fund HBM Healthcare Investments AG (SWX:HBMN), Tybourne Capital Management Limited and 360 One Wam Limited (NSEI:360ONE), to raise about $200 million (INR 16,700 million), said sources.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,183.70 INR | -1.27% |
|
+4.84% | -5.67% |
Oct. 22 | 360 One Wam Limited, H1 2025 Earnings Call, Oct 22, 2024 | |
Oct. 22 | Jefferies Adjusts 360 One Wam's Price Target to INR1,350 From INR1,300, Keeps at Buy | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,183.70INR | -1.27% | +4.84% | 5.3B | ||
182.80CHF | +1.56% | -3.18% | 1.36B | ||
![Consensus](https://cdn.zonebourse.com/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 360ONE Stock
- News 360 One Wam Limited
- OneSource Reportedly in Talks to Raise INR 16,700 Million in Pre-Listing Round